Chronic Cough Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class); Route of Administration (Oral, Injections, Inhalation, Other and Route of Administration); Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy); and Geography

Publication Month: Jun 2020 | Report Code: TIPRE00011584 | No. of Pages: 180 | Category: Pharmaceuticals | Status: Published
Covid

The chronic cough market is expected to reach US$ 9,854.8 million by 2027 from US$ 5,430.0 million in 2019; it is estimated to grow at a CAGR of 7.8% from 2020 to 2027.

 

Chronic cough isdefined as a persistent cough that lasts long up to 6-8 weeks. It significantlyaffects the life of the patients by interrupting sleep, creating vomitingsensation, light-headedness, and even rib fractures. It is caused due tomultiple reasons such as infections, asthma, and gastro esophageal refluxdisease (GERD). The chronic cough market growth is attributed to factors suchas rising incidences of chronic cough and growing product developments to treatchronic cough are expected to drive the growth of the market. However, productrecalls is the major factor hindering the market growth.

Lucrative Regional Markets for Chronic Cough

 

Lucrative Regional Markets for Chronic Cough

Get more information on this report :

 

MarketInsights

Rising Incidences of Chronic Cough

Chronic cough is caused due to asthma, acid reflux from the stomach,and postnasal drip. The conditions such as infection, bronchitis, and lungdiseases are also likely to lead to chronic cough. The condition such as asthmais rising across the world; it is commonly seen among children and adults. Itis a major cause of the growing health burden in the US. For instance,according to the Centers for Disease Control and Prevention (CDC) datapublished in 2019, one among every three people has asthma in the US. AcrossAmerica, over 25 million people live with asthma, which accounts for ~8% inadults, and nearly 8.5% in children.

 

In developing regions such as the Asia Pacific and the Middle East andAfrica, the prevalence of chronic diseases is rising due to pollution andinfections. The countries in these regions are highly populated. Although,cough is a non-communicable disease, it is increasing significantly in thecountries. Several governments are putting their efforts to control theincidences of chronic cough in the respective countries. According to theNational Health Policy 2017, India, premature mortality due to non-communicablediseases, including chronic cough, will be reduced by ~ 25% by 2025.

In the Middle East and Africa, respiratory diseases are rising due toclimatic conditions. The countries surrounded by desserts are prone to the riskof respiratory diseases due to the easy spread of allergens. Over 60 to 70% ofpatients in the countries are diagnosed with respiratory diseases. Anothermajor cause of chronic cough among people in the region is smoking. Nearly 30%of the people are addicted to smoking, which further leads to rising incidencesof chronic cough.

 

Drug Class Insights

Based on drug class, the chronic cough market is segmented into antihistamines,corticosteroids, decongestants, combination drug, antibiotics, acid blockers,and other drug class. The combination drug segment held the largest share ofthe market in 2019 and the same segment is estimated to report the highest CAGRin the market during the forecast period. The growth of the segment isestimated due to benefits offered by the combination drugs such as the use ofcombination drugs can target treatment more than one symptom. Additionally, thecombination of drugs is widely available as over the counter medicines.

 

Global Chronic Cough Market, by Drug Class – 2019 and 2027

 

Global Chronic Cough Market, by Drug Class – 2019 and 2027

Get more information on this report :

 

Route ofAdministration Insights

Based on rout of administration, the chronic cough market is segmentedinto oral, injections, inhalation, and other route of administration. The oral segmentheld the largest share of the market in 2019. However, the inhalation segmentis estimated to register the highest CAGR in the market during the forecast period.

 

DistributionChannel Insights

Based on distribution channel, the chronic cough market is segmentedinto hospital pharmacy, online pharmacy, and retail pharmacy. The hospitalpharmacy segment held the largest share of the market in 2019. However, the onlinepharmacy segment is estimated to register the highest CAGR in the market duringthe forecast period.

 

StrategicInsights

 

Inorganic strategies are the more commonly adopted strategies bycompanies in the chronic cough market, which enables them expand their global footprints,and product and service portfolios. The market players have also adoptedorganic strategies such as product launches strategy to enlarge their global customerbase, which also permits them to maintain their brand name globally.

 

Global Chronic Cough Market – By Drug Class

  • Antihistamines
  • Corticosteroids
  • Decongestants
  • Combination Drug
  • Antibiotics
  • Acid Blockers
  • Other Drug Class

Global Chronic CoughMarket– By Route of Administration

  • Oral
  • Injections
  • Nasal
  • OtherRoute of Administration

Global ChronicCough Market– By Distribution Channel

  • HospitalPharmacy
  • OnlinePharmacy
  • RetailPharmacy

Chronic Cough Market– By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

CompanyProfiles

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Bayer AG,
  • Mylan N.V.
  • Amneal Pharmaceuticals, Inc.
  • Cipla Inc.
  • Reckitt Benckiser Group plc
  • Sun Pharmaceutical Industries Ltd
  • Aurobindo Pharma Ltd

 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Chronic CoughMarket – By Drug Class

1.3.2        Chronic CoughMarket – By Route of Administration

1.3.3        Chronic CoughMarket – By Distribution Channel

1.3.4        Global ChronicCough Market – By Geography

2.             Chronic Cough Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Chronic Cough Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America –PEST Analysis

4.2.2        Europe – PESTAnalysis

4.2.3        Asia Pacific–PEST Analysis

4.2.4        Middle East andAfrica – PEST Analysis

4.2.5        South &Central America

4.3       Expert Opinion

5.             Chronic Cough Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        RisingIncidences of Chronic Cough

5.1.2        Growing ProductDevelopments to Treat Chronic Cough

5.2       Market Restraints

5.2.1        Product Recalls

5.3       Market Opportunities

5.3.1        Aging Populationis Expected to Drive Demand for Chronic Cough Treatment

5.4       Future Trends

5.4.1        Continuous Trendof Drug Development

5.5       Impact Analysis

6.             Chronic Cough Market – Global Analysis

6.1       Global Chronic Cough Market Revenue Forecast And Analysis

6.2       Global Chronic Cough Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Chronic Cough Market Analysis – By Drug Class

7.1       Overview

7.2       Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)

7.3       Antihistamines

7.3.1        Overview

7.3.2        Antihistamines:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.4       Corticosteroids

7.4.1        Overview

7.4.2        Corticosteroids:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.5       Decongestants

7.5.1        Overview

7.5.2        Decongestants:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.6       Combination Drug

7.6.1        Overview

7.6.2        CombinationDrug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.7       Antibiotics

7.7.1        Overview

7.7.2        Antibiotics:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.8       Acid Blockers

7.8.1        Overview

7.8.2        Acid Blockers:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.9       Other Drug Class

7.9.1        Overview

7.9.2        Other DrugClass: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.             Chronic Cough Market – By Route of Administration

8.1       Overview

8.2       Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)

8.3       Oral

8.3.1        Overview

8.3.2        Oral: ChronicCough Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Injections

8.4.1        Overview

8.4.2        Injections:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Inhalation

8.5.1        Overview

8.5.2        Inhalation:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.6       Other Route of Administration

8.6.1        Overview

8.6.2        Other Route ofAdministration: Chronic Cough Market – Revenue and Forecast to 2027 (US$Million)

9.             Chronic Cough Market – By Distribution Channel

9.1       Overview

9.2       Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)

9.3       Hospital Pharmacy

9.3.1        Overview

9.3.2        HospitalPharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

9.4       Online Pharmacy

9.4.1        Overview

9.4.2        Online Pharmacy:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

9.5       Retail Pharmacy

9.5.1        Overview

9.5.2        Retail Pharmacy:Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

10.          Chronic Cough Market – Geographic Analysis

10.1    North America: Chronic Cough Market

10.1.1     Overview

10.1.2     North America:Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     North America:Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

10.1.4     North America:Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

10.1.5     North America:Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

10.1.6     North America:Chronic Cough Market, by Country, 2019 & 2027 (%)

10.1.7     US: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    US: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    US: Chronic CoughMarket, by Drug Class, 2018–2027 (USD Million)

10.1.7.3    US: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)

10.1.7.4    US: Chronic Cough Market,by Distribution Channel , 2018–2027 (USD Million)

10.1.8     Canada: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1    Canada: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    Canada: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)

10.1.8.3    Canada: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)

10.1.8.4    Canada: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)

10.1.9     Mexico: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1    Mexico: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2    Mexico: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)

10.1.9.3    Mexico: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)

10.1.9.4    Mexico: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)

10.2    Europe: Chronic Cough Market

10.2.1     Overview

10.2.2     Europe: ChronicCough Market - Revenue and Forecast to 2027 (USD Million)

10.2.3     Europe: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)

10.2.4     Europe: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)

10.2.5     Europe: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)

10.2.6     Europe: ChronicCough Market, by Country, 2018 & 2027 (%)

10.2.7     Germany: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.1    Germany: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2    Germany: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)

10.2.7.3    Germany: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)

10.2.7.4    Germany: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)

10.2.8     UK: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.2.8.1    UK: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.2.8.2    UK: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)

10.2.8.3    UK: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)

10.2.9     France: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.1    France: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2    France: ChronicCough Market, by Drug Class , 2018–2027 (USD Million)

10.2.9.3    France: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)

10.2.9.4    France: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)

10.2.10   Spain: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.2.10.1 Spain: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.2.10.2 Spain: Chronic CoughMarket, by Drug Class , 2018–2027 (USD Million)

10.2.10.3 Spain: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)

10.2.10.4 Spain: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)

10.2.11   Italy: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.2.11.1 Italy: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.2.11.2 Italy: Chronic CoughMarket, by Drug Class , 2018–2027 (USD Million)

10.2.11.3 Italy: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)

10.2.11.4 Italy: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)

10.3    Asia Pacific: Chronic Cough Market

10.3.1     Overview

10.3.2     Asia Pacific:Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)

10.3.3     Asia Pacific:Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

10.3.4     Asia Pacific:Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

10.3.5     Asia Pacific:Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

10.3.6     Asia Pacific:Chronic Cough Market, by Country, 2019 & 2027 (%)

10.3.7     China: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.1    China: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.3.7.2    China: Chronic CoughMarket, by Drug Class , 2018–2027 (USD Million)

10.3.7.3    China: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)

10.3.7.4    China: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)

10.3.8     Japan: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.1    Japan: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.3.8.2    Japan: Chronic CoughMarket, by Drug Class , 2018–2027 (USD Million)

10.3.8.3    Japan: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)

10.3.8.4    Japan: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)

10.3.9     India: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.1    India: Chronic CoughMarket – Revenue and Forecast to 2027 (USD Million)

10.3.9.2    India: Chronic CoughMarket, by Drug Class , 2018–2027 (USD Million)

10.3.9.3    India: Chronic CoughMarket, by Route of Administration , 2018–2027 (USD Million)

10.3.9.4    India: Chronic CoughMarket, by Distribution Channel , 2018–2027 (USD Million)

10.3.10   South Korea: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.1 South Korea: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.2 South Korea: ChronicCough Market, by Drug Class , 2018–2027 (USD Million)

10.3.10.3 South Korea: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)

10.3.10.4 South Korea: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)

10.3.11   Australia: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.1 Australia: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.2 Australia: ChronicCough Market, by Drug Class , 2018–2027 (USD Million)

10.3.11.3 Australia: ChronicCough Market, by Route of Administration , 2018–2027 (USD Million)

10.3.11.4 Australia: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)

10.4    Middle East and Africa: Chronic Cough Market

10.4.1     Overview

10.4.2     Middle East andAfrica: Chronic Cough Market- Revenue and Forecast to 2027 (USD Million)

10.4.3     Middle East andAfrica: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

10.4.4     Middle East andAfrica: Chronic Cough Market, by Route of Administration, 2018–2027 (USDMillion)

10.4.5     Middle East andAfrica: Chronic Cough, Market, by Distribution Channel, 2018–2027 (USD Million)

10.4.6     Middle East andAfrica: Chronic Cough Market, by Country, 2019 & 2027 (%)

10.4.7     Saudi Arabia:Chronic Cough Market– Revenue and Forecast to 2027 (USD Million)

10.4.7.1    Saudi Arabia:Chronic Cough Market– Revenue and Forecast to 2027 (USD Million)

10.4.7.2    Saudi Arabia:Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

10.4.7.3    Saudi Arabia:Chronic Cough Market, by Route of Administration, 2018–2027 (USD Million)

10.4.7.4    Saudi Arabia:Chronic Cough, Market, by Distribution Channel, 2018–2027 (USD Million)

10.4.8     UAE: Chronic CoughMarket– Revenue and Forecast to 2027 (USD Million)

10.4.8.1    UAE: Chronic CoughMarket– Revenue and Forecast to 2027 (USD Million)

10.4.8.2    UAE: Chronic CoughMarket, by Drug Class, 2018–2027 (USD Million)

10.4.8.3    UAE: Chronic CoughMarket, by Route of Administration, 2018–2027 (USD Million)

10.4.8.4    UAE: Chronic Cough,Market, by Distribution Channel, 2018–2027 (USD Million)

10.4.9     South Africa:Chronic Cough Market– Revenue and Forecast to 2027 (USD Million)

10.4.9.1    South Africa:Chronic Cough Market– Revenue and Forecast to 2027 (USD Million)

10.4.9.2    South Africa:Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

10.4.9.3    South Africa:Chronic Cough Market, by Route of Administration, 2018–2027 (USD Million)

10.4.9.4    South Africa:Chronic Cough, Market, by Distribution Channel, 2018–2027 (USD Million)

10.5    South and Central America: Chronic Cough Market

10.5.1     Overview

10.5.2     South and CentralAmerica: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)

10.5.3     South and CentralAmerica: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

10.5.4     South and CentralAmerica: Chronic Cough Market, by Route of Administration, 2018–2027 (USDMillion)

10.5.5     South and CentralAmerica: Chronic Cough Market, by Distribution Channel, 2018–2027 (USD Million)

10.5.6     South and CentralAmerica: Chronic Cough Market, by Country, 2019 & 2027 (%)

10.5.7     Brazil: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.1    Brazil: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.2    Brazil: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)

10.5.7.3    Brazil: ChronicCough Market, by Route of Administration, 2018–2027 (USD Million)

10.5.7.4    Brazil: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)

10.5.8     Argentina: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.1    Argentina: ChronicCough Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.2    Argentina: ChronicCough Market, by Drug Class, 2018–2027 (USD Million)

10.5.8.3    Argentina: ChronicCough Market, by Route of Administration, 2018–2027 (USD Million)

10.5.8.4    Argentina: ChronicCough Market, by Distribution Channel , 2018–2027 (USD Million)

11.          Impact of COVID-19 Pandemic on Global Chronic cough Market

11.1    North America: Impact Assessment of COVID-19 Pandemic

11.2    Europe: Impact Assessment Of COVID-19 Pandemic

11.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

12.          Chronic Cough Market –Industry Landscape

12.1    Overview

12.2    Growth Strategies in The Chronic Cough Market, 2016-2020

12.3    Inorganic Growth Strategies

12.3.1     Overview

12.4    Organic Growth Strategies

12.4.1     Overview

13.          COMPANY PROFILES

13.1    Novartis AG

13.1.1     Key Facts

13.1.2     BusinessDescription

13.1.3     Products andServices

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    TEVA PHARMACEUTICAL INDUSTRIES LTD

13.2.1     Key Facts

13.2.2     BusinessDescription

13.2.3     Products andServices

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    GlaxoSmithKline plc.

13.3.1     Key Facts

13.3.2     BusinessDescription

13.3.3     Products andServices

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Bayer AG

13.4.1     Key Facts

13.4.2     BusinessDescription

13.4.3     Products andServices

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    MYLAN N.V.

13.5.1     Key Facts

13.5.2     BusinessDescription

13.5.3     Products andServices

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Amneal Pharmaceuticals, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products andServices

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Cipla Inc.

13.7.1     Key Facts

13.7.2     BusinessDescription

13.7.3     Products andServices

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Reckitt Benckiser Group plc.

13.8.1     Key Facts

13.8.2     BusinessDescription

13.8.3     Products andServices

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Sun Pharmaceutical Industries Ltd

13.9.1     Key Facts

13.9.2     BusinessDescription

13.9.3     Products andServices

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Aurobindo Pharma Ltd

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    Glossary of Terms


LIST OF TABLES

Table 1.             North America Chronic Cough Market, by Drug Class – Revenue andForecast to 2027 (USD Million)

Table 2.             North America Chronic Cough Market, by Route of Administration–Revenue and Forecast to 2027  (USDMillion)

Table 3.             North America Chronic Cough Market, by Distribution Channel– Revenueand Forecast to 2027 (USD Million)

Table 4.             US Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 5.             US Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 6.             US Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 7.             Canada Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 8.             Canada Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 9.             Canada Chronic Cough Market, by Distribution Channel– Revenue and Forecastto 2027 (USD Million)

Table 10.          Mexico Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 11.          Mexico Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 12.          Mexico Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 13.          Europe Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 14.          Europe Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 15.          Europe Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 16.          Germany Chronic Cough Market, by Drug Class – Revenue and Forecastto 2027 (USD Million)

Table 17.          Germany Chronic Cough Market, by Route of Administration– Revenueand Forecast to 2027 (USD Million)

Table 18.          Germany Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 19.          UK Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 20.          UK Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 21.          UK Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 22.          France Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 23.          France Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 24.          France Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 25.          Spain Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 26.          Spain Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 27.          Spain Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 28.          Italy Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 29.          Italy Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 30.          Italy Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 31.          Asia Pacific Chronic Cough Market, by Drug Class – Revenue andForecast to 2027 (USD Million)

Table 32.          Asia Pacific Chronic Cough Market, by Route of Administration–Revenue and Forecast to 2027 (USD Million)

Table 33.          Asia Pacific Chronic Cough Market, by Distribution Channel– Revenueand Forecast to 2027 (USD Million)

Table 34.          China Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 35.          China Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 36.          China Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 37.          Japan Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 38.          Japan Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 39.          Japan Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 40.          India Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 41.          India Chronic Cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 42.          India Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 43.          South Korea Chronic Cough Market, by Drug Class – Revenue andForecast to 2027 (USD Million)

Table 44.          South Korea Chronic Cough Market, by Route of Administration–Revenue and Forecast to 2027 (USD Million)

Table 45.          South Korea Chronic Cough Market, by Distribution Channel– Revenueand Forecast to 2027 (USD Million)

Table 46.          Australia Chronic Cough Market, by Drug Class – Revenue and Forecastto 2027 (USD Million)

Table 47.          Australia Chronic Cough Market, by Route of Administration– Revenueand Forecast to 2027 (USD Million)

Table 48.          Australia Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 49.          Middle East and Africa Chronic Cough Market, by Drug Class– Revenueand Forecast to 2027 (USD Million)

Table 50.          Middle East and Africa Chronic Cough Market, by Route ofAdministration– Revenue and Forecast to 2027 (USD Million)

Table 51.          Middle East and Africa Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027  (USDMillion)

Table 52.          Saudi Arabia Chronic Cough Market, by Drug Class– Revenue andForecast to 2027 (USD Million)

Table 53.          Saudi Arabia Chronic Cough Market, by Route of Administration–Revenue and Forecast to 2027 (USD Million)

Table 54.          Saudi Arabia Chronic Cough Market, by Distribution Channel – Revenueand Forecast to 2027 (USD Million)

Table 55.          UAE Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 56.          UAE Chronic cough Market, by Route of Administration– Revenue andForecast to 2027 (USD Million)

Table 57.          UAE Chronic Cough Market, by Distribution Channel – Revenue andForecast to 2027 (USD Million)

Table 58.          South Africa Chronic Cough Market, by Drug Class– Revenue andForecast to 2027 (USD Million)

Table 59.          South Africa Chronic Cough Market, by Route of Administration–Revenue and Forecast to 2027 (USD Million)

Table 60.          South Africa Chronic Cough Market, by Distribution Channel – Revenueand Forecast to 2027 (USD Million)

Table 61.          South and Central America Chronic Cough Market, by Drug Class –Revenue and Forecast to 2027  (USDMillion)

Table 62.          South and Central America Chronic Cough Market, by Route ofAdministration – Revenue and Forecast to 2027 (USD Million)

Table 63.          South and Central America Chronic Cough Market, by DistributionChannel– Revenue and Forecast to 2027 (USD Million)

Table 64.          Brazil Chronic Cough Market, by Drug Class – Revenue and Forecast to2027 (USD Million)

Table 65.          Brazil Chronic Cough Market, by Route of Administration – Revenueand Forecast to 2027 (USD Million)

Table 66.          Brazil Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 67.          Argentina Chronic Cough Market, by Drug Class – Revenue and Forecastto 2027 (USD Million)

Table 68.          Argentina Chronic Cough Market, by Route of Administration – Revenueand Forecast to 2027 (USD Million)

Table 69.          Argentina Chronic Cough Market, by Distribution Channel– Revenue andForecast to 2027 (USD Million)

Table 70.          Recent Inorganic Growth Strategies in the chronic cough Market

Table 71.          Recent Organic Growth Strategies In The Chronic Cough Market

Table 72.          Glossary of Terms, Chronic Cough Market

 


LIST OF FIGURES

Figure 1.           Chronic Cough Market Segmentation

Figure 2.           Chronic Cough Market – By Geography

Figure 3.           Global Chronic Cough Market Overview

Figure 4.           Combination Drug Segment Held Largest Share of Chronic Cough Market

Figure 5.           Asia Pacific to Show Remarkable Growth During Forecast Period

Figure 6.           Global Chronic Cough Market, By Geography (US$ Million)

Figure 7.           Global Chronic Cough Market, Industry Landscape

Figure 8.           Global Chronic Cough Market- Leading Country Markets (US$ Million)

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa PEST Analysis

Figure 13.        South & Central America PEST Analysis

Figure 14.        Expert Opinion

Figure 15.        Chronic Cough Market Impact Analysis of Drivers and Restraints

Figure 16.        Global Chronic Cough Market – Revenue Forecast And Analysis – 2019-2027

Figure 17.        Global Chronic Cough Market – By Geography Forecast and Analysis –2019- 2027

Figure 18.        Market Positioning of Key Players

Figure 19.        Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)

Figure 20.        Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)

Figure 21.        Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)

Figure 22.        Decongestants: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)

Figure 23.        Combination Drug: Chronic Cough Market – Revenue and Forecast to2027 (US$ Million)

Figure 24.        Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)

Figure 25.        Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)

Figure 26.        Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)

Figure 27.        Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)

Figure 28.        Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$Million)

Figure 29.        Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$Million)

Figure 30.        Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$Million)

Figure 31.        Other Route of Administration: Chronic Cough Market – Revenue andForecast to 2027 (US$ Million)

Figure 32.        Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)

Figure 33.        Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to2027 (US$ Million)

Figure 34.        Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)

Figure 35.        Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027(US$ Million)

Figure 36.        North America: Chronic Cough Market, by Key Country – Revenue (2019)(USD Million)

Figure 37.        North America Chronic Cough Market Revenue and Forecast to 2027 (USDMillion)

Figure 38.        North America: Chronic Cough Market, by Country, 2019 & 2027 (%)

Figure 39.        US: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 40.        Canada: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 41.        Mexico: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 42.        Europe: Chronic Cough Market, by Key Country – Revenue (2019) (USDMillion)

Figure 43.        Europe Chronic Cough Market Revenue and Forecast to 2027 (USDMillion)

Figure 44.        Europe: Chronic Cough Market, by Country, 2018 & 2027 (%)

Figure 45.        Germany: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 46.        UK: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 47.        France: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 48.        Spain: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 49.        Italy: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 50.        Asia Pacific: Chronic Cough Market, by Key Country – Revenue (2019)(USD Million)

Figure 51.        Asia Pacific Chronic Cough Market Revenue and Forecast to 2027 (USDMillion)

Figure 52.        China: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 53.        Japan: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 54.        India: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 55.        South Korea: Chronic Cough Market – Revenue and Forecast to 2027(USD Million)

Figure 56.        Australia: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 57.        Middle East and Africa: Chronic Cough Market, by Key Country –Revenue (2019) (USD Million)

Figure 58.        Middle East and Africa Chronic Cough Market Revenue and Forecast to2027 (USD Million)

Figure 59.        Middle East and Africa: Chronic Cough Market, by Country, 2019 &2027 (%)

Figure 60.        Saudi Arabia: Chronic Cough Market– Revenue and Forecast to 2027(USD Million)

Figure 61.        UAE: Chronic Cough Market– Revenue and Forecast to 2027 (USDMillion)

Figure 62.        South Africa: Chronic Cough Market– Revenue and Forecast to 2027(USD Million)

Figure 63.        South and Central America: Chronic Cough Market, by Key Country –Revenue (2019) (USD Million)

Figure 64.        South and Central America Chronic Cough Market Revenue and Forecastto 2027 (USD Million)

Figure 65.        South and Central America: Chronic Cough Market, by Country, 2019& 2027 (%)

Figure 66.        Brazil: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 67.        Argentina: Chronic Cough Market – Revenue and Forecast to 2027 (USDMillion)

Figure 68.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 69.        Impact of COVID-19 Pandemic in European Country Markets

Figure 70.        Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

Figure 71.        Impact Of COVID-19 Pandemic in Rest of the World Countries Market

Figure 72.        Growth Strategies in The Chronic Cough Market, 2016-2020

 

 

The List of Companies - Chronic Cough Market

 

  1. NovartisAG
  2. TevaPharmaceutical Industries Ltd
  3. GlaxoSmithKlineplc.
  4. BayerAG
  5. MylanN.V.
  6. AmnealPharmaceuticals, Inc.
  7. CiplaInc.
  8. ReckittBenckiser Group plc.
  9. SunPharmaceutical Industries Ltd
  10. AurobindoPharma Ltd

 

  • Save and reducetime carrying out entry-level research by identifying the growth, size, leadingplayers and segments in the chronic cough market.

 

  • Highlights keybusiness priorities in order to assist companies to realign their businessstrategies.

 

  • The keyfindings and recommendations highlight crucial progressive industry trends inthe global chronic cough market, thereby allowing players across the valuechain to develop effective long-term strategies.

 

  • Develop/modifybusiness expansion plans by using substantial growth offering developed andemerging markets.

 

  • Scrutinizein-depth global market trends and outlook coupled with the factors driving themarket, as well as those hindering it.

 

  • Enhance thedecision-making process by understanding the strategies that underpin securityinterest with respect to client products, segmentation, pricing anddistribution

 

TIPRE00011584
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastro esophageal reflux disease (GERD), among others.

The growth of market is likely to grow due to factors such as rising incidences of chronic cough and growing product developments to treat chronic cough are expected to drive the growth of the market. However, product recall is the major factor hindering the market growth.

The cost of chronic cough medicine starts from US$ 2 and above. The price of medicine depends upon the type of drug, whether it is tablet, syrup, or nasal spray. The generic and OTC drugs are much cheaper compared to the branded and prescribed ones.

Pricing